Your session is about to expire
← Back to Search
RESToRE for Long COVID Syndrome (RESToRE Trial)
RESToRE Trial Summary
This trial will investigate if aerobic/breathing exercises can help people with long COVID. Participants will do a tailored 6-week home exercise program supervised by therapists.
RESToRE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.RESToRE Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the magnitude of people enrolled in this experiment?
"Affirmative. Clinicaltrials.gov indicates that this trial is still open for recruitment, having been initially posted on October 1st 2023 and last updated on December 14th 2023. Currently, the study needs to find 20 volunteers at a single location."
Is the study open to those of advanced age?
"To qualify for this medical trial, one must be aged 18 to 70. Additionally, there are 11 trials specifically designed for minors and 127 clinical studies targeting senior citizens."
Is this research project recruiting participants at present?
"Affirmative, the information on clinicaltrials.gov demonstrates that this medical trial is actively enrolling participants. It was first posted on October 1st 2023 and has since been updated on December 14th with a goal of recruiting 20 patients from one site."
Is it possible for me to become part of this experiment?
"To become eligible for this trial, applicants must be afflicted with long covid syndrome and within the age range of 18-70. Approximately 20 patients are needed to participate in the program."
What are the primary objectives of this clinical investigation?
"The primary outcome for this 10-week medical trial is the total number of participants who completed. Secondary outcomes include PROMIS-29 scale score (1-5, higher scores indicating worse quality of life), Rand 36-Item Health Survey (SF-36) score (1-6, higher scores correlating with poorer health outcomes), and General Symptom Questionnaire (SGQ30) score(0 - 4, greater values pointing to severe symptomology)."
Share this study with friends
Copy Link
Messenger